CHROMOSOME DAMAGE AFTER 131I THERAPY

被引:0
|
作者
不详
机构
来源
NEW ENGLAND JOURNAL OF MEDICINE | 1966年 / 275卷 / 14期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:786 / &
相关论文
共 50 条
  • [41] Study supports outpatient status for 131I therapy
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (06) : 28N - 28N
  • [42] Radiation safety evaluation for patients with 131I therapy
    Lu Ke-yi
    Li Xian-feng
    Hu Guang
    Liu Jian-zhong
    Li Si-Jin
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50
  • [43] 131I lipiodol therapy for unresectable hepatocellular carcinoma
    Rindani, RB
    Hugh, TJ
    Roche, J
    Roach, PJ
    Smith, RC
    ANZ JOURNAL OF SURGERY, 2002, 72 (03) : 210 - 214
  • [44] FRACTIONATED 131I THERAPY IN LARGE TOXIC GOITRES
    SATERBOR.NE
    EINHORN, J
    ACTA ENDOCRINOLOGICA, 1966, 51 (01): : 7 - &
  • [45] Factors affecting 131I therapy radiation dose
    Nichols, Kenneth
    Tomas, Maria-Bernadette
    Tronco, Gene
    Leveque, Fritzgerald
    Bhargava, Kuldeep
    Palestro, Christopher
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [46] 131I imaging in the therapy of differentiated thyroid cancer
    Vija, L. -M.
    Toubert, M. -E.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2012, 36 (01): : 44 - 51
  • [47] Thyroid Cancer Therapy with 131I: A Comprehensive Review
    Rodriguez-Santiago, Stephanie
    Cantu, Ernesto
    Wagner, Robert
    Savir-Baruch, Bital
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [48] Release criteria for 131I therapy patients.
    Richard, ML
    HEALTH PHYSICS, 2002, 82 (06): : S193 - S193
  • [49] 131I tositumomab
    Culy, CR
    Lamb, HM
    BIODRUGS, 2000, 14 (03) : 195 - 202
  • [50] Epiphora and xerophthalmia after 131I therapy: The frequency, time of onset, severity, and duration
    Orquiza, Michael
    Khorjekar, Gauri
    Schneider, Mark
    Kulkarni, Kanchan
    Garcia, Carlos
    Acio, Elmo
    Mete, Mihriye
    Burman, Kenneth
    Wartofsky, Leonard
    Van Nostrand, Douglas
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55